when is retatrutide coming to market The FDA has issued warning letters multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight-loss results, Retatrutide – new weight loss

Meighan Vargas has been advocating for clients since 2011, bringing more than a decade of trial and litigation experience to her personal injury practice at

UChicago Medicine bariatric surgeon Vanessa Buie, MD, MBA, explains the benefits of surgery as a long-term alternative to taking GLP-1 medications

Botanical Blend: Infused with ingredients like Berberine, Pomegranate, Cinnamon, and L-Glutamine, these patches offer a natural, plant-based solution for your daily wellness routine

Int J Endocrinol

consumers between 16 and 65 years of age, and found that Ozempic topped all health care brands considered in the study beating the companies CVS (Health), Warby Parker (a perennial health consumer favorite in other research), Pfizer (still associated with the COVID-19 vaccine) and Truvani (a brand of protein powder)

By the end of 2024, GLP-1 volume had surpassed 9M prescriptions